Articles with public access mandates - David A. SolomonLearn more
Not available anywhere: 5
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective
R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ...
Cell 187 (2), 446-463. e16, 2024
Mandates: Chan Zuckerberg Initiative
Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker
M Pekmezci, JJ Phillips, F Dirilenoglu, T Atasever-Rezanko, T Tihan, ...
Acta Neuropathologica 139, 597-600, 2020
Mandates: US National Institutes of Health
A review of recently described genetic alterations in central nervous system tumors
CHG Lucas, DA Solomon, A Perry
Human pathology 96, 56-66, 2020
Mandates: US National Institutes of Health
Eye-sparing treatment of localized orbital medulloepithelioma with neoadjuvant chemoradiation
RA Gallo, J Shoag, TE Johnson, DA Solomon, A Perry, A Podda, JY Lee, ...
Ophthalmic Plastic & Reconstructive Surgery 37 (1), e13-e16, 2021
Mandates: US National Institutes of Health
Next-Generation Sequencing of Newly-Diagnosed Primary CNS Lymphoma Reveals Alterations in BTG1, ETV6, and 6p Are Associated with Chemoresistance and Inferior Progression-Free …
SS Mo, H Geng, M Cerejo, KW Wen, DA Solomon, JL Rubenstein
Blood 140 (Supplement 1), 3516-3517, 2022
Mandates: US National Institutes of Health
Available somewhere: 131
Mutational inactivation of STAG2 causes aneuploidy in human cancer
DA Solomon, T Kim, LA Diaz-Martinez, J Fair, AG Elkahloun, BT Harris, ...
Science 333 (6045), 1039-1043, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma
R Hashizume, N Andor, Y Ihara, R Lerner, H Gan, X Chen, D Fang, ...
Nature medicine 20 (12), 1394-1396, 2014
Mandates: US National Institutes of Health
The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ...
PLoS genetics 10 (7), e1004475, 2014
Mandates: US National Institutes of Health
Diffuse midline gliomas with histone H3‐K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations
DA Solomon, MD Wood, T Tihan, AW Bollen, N Gupta, JJJ Phillips, ...
Brain pathology 26 (5), 569-580, 2016
Mandates: US National Institutes of Health
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ...
The Lancet Oncology 19 (6), 785-798, 2018
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts
K Michaud, DA Solomon, E Oermann, JS Kim, WZ Zhong, MD Prados, ...
Cancer research 70 (8), 3228-3238, 2010
Mandates: US National Institutes of Health
Frequent truncating mutations of STAG2 in bladder cancer
DA Solomon, JS Kim, J Bondaruk, SF Shariat, ZF Wang, AG Elkahloun, ...
Nature genetics 45 (12), 1428-1430, 2013
Mandates: US National Institutes of Health
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
CN Kline, NM Joseph, JP Grenert, J van Ziffle, E Talevich, C Onodera, ...
Neuro-oncology 19 (5), 699-709, 2017
Mandates: US National Institutes of Health
Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes
M Clarke, A Mackay, B Ismer, JC Pickles, RG Tatevossian, S Newman, ...
Cancer discovery 10 (7), 942-963, 2020
Mandates: US National Institutes of Health, Helmholtz Association, Cancer Research UK …
Targeted Therapy for BRAFV600E Malignant Astrocytoma
TP Nicolaides, H Li, DA Solomon, S Hariono, R Hashizume, K Barkovich, ...
Clinical Cancer Research 17 (24), 7595-7604, 2011
Mandates: US National Institutes of Health
The genetic landscape of ganglioglioma
M Pekmezci, JE Villanueva-Meyer, B Goode, J Van Ziffle, C Onodera, ...
Acta neuropathologica communications 6, 1-11, 2018
Mandates: US National Institutes of Health
Imaging characteristics of pediatric diffuse midline gliomas with histone H3 K27M mutation
MS Aboian, DA Solomon, E Felton, MC Mabray, JE Villanueva-Meyer, ...
American Journal of Neuroradiology 38 (4), 795-800, 2017
Mandates: US National Institutes of Health
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma
DA Solomon, JS Kim, JC Cronin, Z Sibenaller, T Ryken, SA Rosenberg, ...
Cancer research 68 (24), 10300-10306, 2008
Mandates: US National Institutes of Health
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities
A Choudhury, ST Magill, CD Eaton, BC Prager, WC Chen, MA Cady, ...
Nature genetics 54 (5), 649-659, 2022
Mandates: US National Institutes of Health
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genes
CG Duncan, PJ Killela, CA Payne, B Lampson, WC Chen, J Liu, ...
Oncotarget 1 (4), 265, 2010
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program